Funding for this research was provided by:
Text and Data Mining valid from 2019-06-21
Received: 16 May 2018
Accepted: 6 June 2019
First Online: 21 June 2019
Ethics approval and consent to participate
: All procedures were conducted under Western Institutional Review Board (WIRB, ExternalRef removed) protocol ADAP-002 (“Immunology studies of normal healthy individuals”). Subject enrollment and study procedures were directed by Adaptive Biotechnologies. Written, informed consent was obtained from all study participants.
: Not applicable.
: AMS and ROE are employed by, and have equity ownership with, Adaptive Biotechnologies. HSR has equity ownership with Adaptive Biotechnologies. EJA is a consultant and research advisor of OpenBiome and Finch Therapeutics. The remaining authors have no competing interest to declare.